4//SEC Filing
Galena Biopharma, Inc. 4
Accession 0001394548-16-000004
$SLSCIK 0001390478operating
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 5:12 PM ET
Size
6.5 KB
Accession
0001394548-16-000004
Insider Transaction Report
Form 4
Knapp Thomas J
General Counsel
Transactions
- Award
Stock Option (right to buy)
2016-10-25+102,000→ 102,000 totalExercise: $0.29Exp: 2026-10-25→ Common Stock (102,000 underlying)
Footnotes (3)
- [F1]Granted pursuant to the Issuer's 2016 Incentive Plan.
- [F2]The Reporting Person obtained the securities pursuant to an Employment Agreement Amendment dated October 1, 2016. The securities were convertible into common stock at the rate of 1 share of common stock for each 1 stock option share, or an aggregate of 102,000 shares of common stock (pre-reverse stock split). The securities were converted into 5,100 stock options at a price of $5.744 per share (post-reverse split) as of November 14, 2016.
- [F3]This stock option vests in equal monthly installments beginning November 25, 2016 and ending March 31, 2017.
Documents
Issuer
Galena Biopharma, Inc.
CIK 0001390478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001390478
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 5:12 PM ET
- Size
- 6.5 KB